谷歌浏览器插件
订阅小程序
在清言上使用

610O Preliminary Results from a Phase I, First-in-human Study of DS-9606a, a Claudin 6 (Cldn6)-Directed Antibody-Drug Conjugate (ADC), in Patients (pts) with Tumor Types Known to Express CLDN6

Annals of Oncology(2024)

引用 0|浏览3
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要